KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Total Non-Current Liabilities (2016 - 2025)

Historic Total Non-Current Liabilities for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to $1.5 billion.

  • Evolent Health's Total Non-Current Liabilities rose 2871.3% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 2871.3%. This contributed to the annual value of $1.2 billion for FY2024, which is 613.57% down from last year.
  • As of Q3 2025, Evolent Health's Total Non-Current Liabilities stood at $1.5 billion, which was up 2871.3% from $1.2 billion recorded in Q2 2025.
  • In the past 5 years, Evolent Health's Total Non-Current Liabilities ranged from a high of $1.5 billion in Q3 2025 and a low of $636.6 million during Q3 2021
  • Moreover, its 5-year median value for Total Non-Current Liabilities was $1.2 billion (2024), whereas its average is $1.0 billion.
  • As far as peak fluctuations go, Evolent Health's Total Non-Current Liabilities skyrocketed by 386231.21% in 2021, and later tumbled by 1101.27% in 2024.
  • Evolent Health's Total Non-Current Liabilities (Quarter) stood at $720.3 million in 2021, then rose by 26.6% to $911.9 million in 2022, then soared by 45.43% to $1.3 billion in 2023, then decreased by 6.14% to $1.2 billion in 2024, then rose by 20.74% to $1.5 billion in 2025.
  • Its last three reported values are $1.5 billion in Q3 2025, $1.2 billion for Q2 2025, and $1.4 billion during Q1 2025.